A study by Monash University researchers has revealed the way a protein important in immune cell signalling can amplify the immune response, which could potentially benefit vaccine design.
The study, led by Department of Immunology and Pathology scientists Professor David Tarlinton and Dr Isaak Quast, is now published in the prestigious journal Immunity.
It identified, in animal models, specifically how the messenger cytokine Interleukin-21 (IL-21) works on the T cells and B cells involved in the body’s immune response.
